Results 111 to 120 of about 11,052 (225)
Comparative Analysis of Progestin Intervention for Non-Atypical Endometrial Hyperplasia in Infertile Females with Anovulation: A Retrospective Study. [PDF]
Zhang X +6 more
europepmc +1 more source
Among 170,250 UK Biobank women (2006–2024), ever HRT use was associated with higher incident ASCVD risk (adjusted HR 1.13, 95% CI 1.08–1.18), largely driven by ischemic stroke. Associations were stronger in women ≤45 years and during perimenopause. Mediation via sex hormones, inflammatory markers, or lipids was minimal (<2%).
Mengchun Wang +6 more
wiley +1 more source
Distinct immunomodulatory effects of synthetic progestins compared with natural progesterone in human immune cells. [PDF]
Patel AJ +4 more
europepmc +1 more source
Abstract Purpose Hormonal replacement therapy (HRT) in postmenopausal women appears to affect glaucoma risk, but findings are inconsistent. We aimed to explore whether the use of postmenopausal HRT plays a role in glaucoma development in Finland. Methods The main outcome variable was glaucoma incidence measured by initiation of special reimbursement ...
Sirpa Loukovaara, Jari Haukka
wiley +1 more source
Does the use of hormonal contraceptives induce negative metacognitions, brooding, and depressive symptoms in an adolescent community sample? [PDF]
Kennair LEO +7 more
europepmc +1 more source
Basal body temperature as a biomarker of reproductive state in ewes: A multi‐method comparison
This study quantified body temperature dynamics throughout reproductive stages in crossbred ewes based on complementary monitoring techniques. Five ewes from a semi‐extensive farming system were included in two sub‐trials: animals were first assessed in the prepubertal stage and, subsequently, an oestrous cycle was induced by intravaginal progesterone ...
E Pérez‐García +4 more
wiley +1 more source
Exogenous Hormones and Their Clinical Implications for the Development and Growth of Meningioma Tumours. [PDF]
Roy H, Stavrakas M, Muquit S.
europepmc +1 more source
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund +5 more
wiley +1 more source
Aime Patrick Niyomugabo, Olufunke Onaadepo, Leopold Ntakirutimana, Muluken Walle Birhanie, Onyinye Cynthia Okeke, Abdul-Rahuf Aderemi Feyitimi, Ejike Daniel Eze, Abdulazeez Jimoh, Abdullateef Isiaka Alagbonsi, Makinde Vincent OlubiyiDepartment of Medical
Niyomugabo AP +9 more
doaj
Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep. [PDF]
Hirose A +6 more
europepmc +1 more source

